UnitedHealth Group Incorporated filed a current report on November 9, 2026, disclosing the appointment of Madeline Bell as an independent director of the company, effective November 3, 2026.

Key Highlights

  • New independent director: Madeline Bell was appointed to the UnitedHealth Group Board of Directors, effective November 3, 2026.
  • No committee assignments yet: According to the filing, Ms. Bell has not yet been appointed to any committees of the Board of Directors.
  • Standard director compensation: Ms. Bell will receive compensation in accordance with the company's standard compensation program for non-employee directors, as described in the company's 2026 proxy statement.
  • Indemnification agreement: The company is entering into its standard form of indemnification agreement with Ms. Bell, based on the form filed as Exhibit 10.1 on July 1, 2015.
  • No related-party transactions: The filing states Ms. Bell has no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
  • No outside arrangements: The filing discloses that there are no arrangements or understandings between Ms. Bell and any other person pursuant to which she was appointed.

UnitedHealth Group Adds Independent Director to Its Board

UnitedHealth Group Incorporated (NYSE:UNH), a Delaware-incorporated managed care and health services company headquartered in Eden Prairie, Minnesota, reported the addition of Madeline Bell to its Board of Directors. According to the filing, the appointment became effective November 3, 2026, and was announced via a press release issued on November 9, 2026. The company noted that Ms. Bell has not yet been assigned to any board committees.

The filing states that Ms. Bell's director compensation will follow the company's standard non-employee director compensation program, the material terms of which are described in the company's 2026 proxy statement. In keeping with what the filing describes as the company's "customary practice," UnitedHealth Group is also entering into its standard indemnification agreement with Ms. Bell, which the filing says "requires the Company to indemnify her against certain liabilities that may arise as a result of her status or service as a director." The filing notes that the full text of the indemnification agreement form was originally filed as Exhibit 10.1 to a current report submitted on July 1, 2015.

The filing further confirms that Ms. Bell's appointment was not made pursuant to any arrangement or understanding with any other person, and that she has no direct or indirect material interest in any transaction that would require disclosure under Item 404(a) of Regulation S-K. The report was signed by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary of UnitedHealth Group.

What Was Disclosed

UnitedHealth Group disclosed the appointment of Madeline Bell as an independent director effective November 3, 2026, covering her compensation arrangement, a standard indemnification agreement, the absence of committee assignments, and confirmation of no related-party transaction interests or outside appointment arrangements.